Dietary Docosahexaenoic Acid Supplementation Alters Select Physiological Endocannabinoid-system Metabolites in Brain and Plasma

Overview

Journal J Lipid Res

Publisher Elsevier

Specialty Biochemistry

Date 2010 Jan 15

PMID 20071693

Citations 61

Authors

JodiAnne T Wood

John S Williams

Lakshmipathi Pandarinathan

David R Janero

Carol J Lammi-Keefe

Alexandros Makriyannis

Affiliations

Soon will be listed here.

Abstract

The endocannabinoid metabolome consists of a growing, (patho)physiologically important family of fatty-acid derived signaling lipids. Diet is a major source of fatty acid substrate for mammalian endocannabinoid biosynthesis. The principal long-chain PUFA found in mammalian brain, docosahexaenoic acid (DHA), supports neurological function, retinal development, and overall health. The extent to which dietary DHA supplementation influences endocannabinoid-related metabolites in brain, within the context of the circulating endocannabinoid profile, is currently unknown. We report the first lipidomic analysis of acute 2-week DHA dietary supplementation effects on the physiological state of 15 fatty-acid, N-acylethanolamine, and glycerol-ester endocannabinoid metabolome constituents in murine plasma and brain. The DHA-rich diet markedly elevated DHA, eicosapentaenoic acid, 2-eicosapentanoylglycerol (EPG), and docosahexanoylethanolamine in both compartments. Dietary DHA enhancement generally affected the synthesis of the N-acyl-ethanolamine and glycerol-ester metabolites to favor the docosahexaenoic and eicosapentaenoic vs. arachidonoyl and oleoyl homologs in both brain and plasma. The greater overall responsiveness of the endocannabinoid metabolome in plasma versus brain may reflect a more circumscribed homeostatic response range of brain lipids to dietary DHA supplementation. The ability of short-term DHA enhancement to modulate select constituents of the physiological brain and plasma endocannabinoid metabolomes carries metabolic and therapeutic implications.

Citing Articles

Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review.

Fuentes J, Mayans J, Guarro M, Canosa I, Mestre-Pinto J, Fonseca F BMC Psychiatry. 2024; 24(1):551.

PMID: 39118031 PMC: 11308641. DOI: 10.1186/s12888-024-05986-8.

Omega-3 Recovers Cannabinoid 1 Receptor Expression in the Adult Mouse Brain after Adolescent Binge Drinking.

Martin-Llorente A, Serrano M, Bonilla-Del Rio I, Lekunberri L, Ocerin G, Puente N Int J Mol Sci. 2023; 24(24).

PMID: 38139145 PMC: 10744058. DOI: 10.3390/ijms242417316.

Dietary linoleic acid lowering alone does not lower arachidonic acid or endocannabinoids among women with overweight and obesity: A randomized, controlled trial.

Courville A, Majchrzak-Hong S, Yang S, Turner S, Wilhite B, Ness Shipley K Lipids. 2023; 58(6):271-284.

PMID: 38100748 PMC: 10767670. DOI: 10.1002/lipd.12382.

Effect of Docosahexaenoic Acid Encapsulation with Whey Proteins on Rat Growth and Tissue Endocannabinoid Profile.

Wang J, Ossemond J, Le Gouar Y, Boissel F, Dupont D, Pedrono F Nutrients. 2023; 15(21).

PMID: 37960275 PMC: 10650154. DOI: 10.3390/nu15214622.

Dietary food patterns as determinants of the gut microbiome-endocannabinoidome axis in humans.

Castonguay-Paradis S, Perron J, Flamand N, Lamarche B, Raymond F, Di Marzo V Sci Rep. 2023; 13(1):15702.

PMID: 37735572 PMC: 10514042. DOI: 10.1038/s41598-023-41650-z.

References

Bradshaw H, Walker J . The expanding field of cannabimimetic and related lipid mediators. Br J Pharmacol. 2005; 144(4):459-65. PMC: 1576036. DOI: 10.1038/sj.bjp.0706093. View

Batetta B, Griinari M, Carta G, Murru E, Ligresti A, Cordeddu L . Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J Nutr. 2009; 139(8):1495-501. DOI: 10.3945/jn.109.104844. View

Connor W, Neuringer M, Lin D . Dietary effects on brain fatty acid composition: the reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys. J Lipid Res. 1990; 31(2):237-47. View

Rapoport S, Rao J, Igarashi M . Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins Leukot Essent Fatty Acids. 2007; 77(5-6):251-61. PMC: 2725409. DOI: 10.1016/j.plefa.2007.10.023. View

Lim S, Suzuki H . Changes in maze behavior of mice occur after sufficient accumulation of docosahexaenoic acid in brain. J Nutr. 2001; 131(2):319-24. DOI: 10.1093/jn/131.2.319. View

Berger A, Crozier G, Bisogno T, Cavaliere P, Innis S, Di Marzo V . Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci U S A. 2001; 98(11):6402-6. PMC: 33480. DOI: 10.1073/pnas.101119098. View

Adibhatla R, Hatcher J . Altered lipid metabolism in brain injury and disorders. Subcell Biochem. 2008; 49:241-68. PMC: 2293298. DOI: 10.1007/978-1-4020-8831-5_9. View

Ligresti A, Petrosino S, Di Marzo V . From endocannabinoid profiling to 'endocannabinoid therapeutics'. Curr Opin Chem Biol. 2009; 13(3):321-31. DOI: 10.1016/j.cbpa.2009.04.615. View

Simopoulos A . The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood). 2008; 233(6):674-88. DOI: 10.3181/0711-MR-311. View

10.

Higuchi T, Shirai N, Suzuki H . Effects of dietary herring roe lipids on plasma lipid, glucose, insulin, and adiponectin concentrations in mice. J Agric Food Chem. 2009; 54(10):3750-5. DOI: 10.1021/jf0531712. View

11.

Hill M, Miller G, Ho W, Gorzalka B, Hillard C . Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Pharmacopsychiatry. 2008; 41(2):48-53. PMC: 3422568. DOI: 10.1055/s-2007-993211. View

12.

Williams J, Pandarinathan L, Wood J, Vouros P, Makriyannis A . Endocannabinoid metabolomics: a novel liquid chromatography-mass spectrometry reagent for fatty acid analysis. AAPS J. 2007; 8(4):E655-60. PMC: 2751361. DOI: 10.1208/aapsj080474. View

13.

Emken E, Adlof R, Rohwedder W, Gulley R . Influence of linoleic acid on desaturation and uptake of deuterium-labeled palmitic and stearic acids in humans. Biochim Biophys Acta. 1993; 1170(2):173-81. DOI: 10.1016/0005-2760(93)90068-k. View

14.

Brenna J, Diau G . The influence of dietary docosahexaenoic acid and arachidonic acid on central nervous system polyunsaturated fatty acid composition. Prostaglandins Leukot Essent Fatty Acids. 2007; 77(5-6):247-50. PMC: 2174532. DOI: 10.1016/j.plefa.2007.10.016. View

15.

Harris W, Kris-Etherton P, Harris K . Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep. 2008; 10(6):503-9. DOI: 10.1007/s11883-008-0078-z. View

16.

Madsen L, Rustan A, Vaagenes H, Berge K, Dyroy E, Berge R . Eicosapentaenoic and docosahexaenoic acid affect mitochondrial and peroxisomal fatty acid oxidation in relation to substrate preference. Lipids. 1999; 34(9):951-63. DOI: 10.1007/s11745-999-0445-x. View

17.

Astarita G, Geaga J, Ahmed F, Piomelli D . Targeted lipidomics as a tool to investigate endocannabinoid function. Int Rev Neurobiol. 2009; 85:35-55. DOI: 10.1016/S0074-7742(09)85004-6. View

18.

Wainwright P, Xing H, Mutsaers L, McCutcheon D, Kyle D . Arachidonic acid offsets the effects on mouse brain and behavior of a diet with a low (n-6):(n-3) ratio and very high levels of docosahexaenoic acid. J Nutr. 1997; 127(1):184-93. DOI: 10.1093/jn/127.1.184. View

19.

Borrelli F, Izzo A . Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance. Best Pract Res Clin Endocrinol Metab. 2009; 23(1):33-49. DOI: 10.1016/j.beem.2008.10.003. View

20.

Higuchi T, Shirai N, Suzuki H . Reduction in plasma glucose after lipid changes in mice fed fish oil, docosahexaenoic acid, and eicosapentaenoic acid diets. Ann Nutr Metab. 2006; 50(2):147-54. DOI: 10.1159/000090671. View